Sunrise Sectors: Meaning & Industries Driving India’s Growth

What Does "Sunrise Sector" Even Mean?

Simply put, a sunrise sector is an industry that has not hit its peak yet but clearly has the wind behind it. These are not businesses riding on past glory. They are  industries where the big jobs, the big revenues, and the real global ambitions are still being built out. They attract heavy investment, push companies to constantly innovate, and usually revolve around technologies that are either brand new or changing faster than most of us can follow.

Think about India's IT industry thirty years ago. No one was entirely sure it would become what it eventually did, one of the country's largest employers and a major source of foreign exchange. The sectors we are talking about today are at a comparable stage. The foundation is there. The ceiling is still being figured out.

Across history, sunrise industries have shared certain patterns:  rapid growth, rising investor excitement, and a tendency to quietly disrupt older, slower industries in the process. Those older ones, unable to adapt, are what people call sunset industries. Clean energy, social media, cloud computing, blockchain, these all went through their sunrise phase at different points over the last two decades.

So What Are India's Sunrise Sectors Right Now?

Electronics and Semiconductors

This one has had a genuinely striking run. Production in India's electronics sector grew roughly sixfold between 2014-15 and 2024-25, going from around ₹1.9 lakh crore to an estimated ₹11.3 lakh crore. Exports grew eightfold in the same window. Mobile phones did a lot of the heavy lifting, production jumped from ₹20,000 crore to approximately ₹5.5 lakh crore, while exports went up more than a hundredfold.

In FY26, total electronics exports reached $47.96 billion, a 24% jump YoY. The US alone imported $19.68 billion worth of Indian electronics, nearly double what it did the year before.

For the semiconductor sector, the Union Budget 2026–27 launched India Semiconductor Mission (ISM) 2.0, allocating ₹1,000 crore for FY 2026–27. The broader manufacturing programme carries an outlay of ₹8,000 crore, and the wider mission has committed ₹76,000 crore in total, with around ₹65,000 crore already deployed. Twenty-four semiconductor design startups are operating under it. With 5G rolling out and connected devices multiplying, demand isn't going anywhere.

Renewable Energy

India is now the third largest country in the world for renewable energy installed capacity, having overtaken Brazil. As of March 2026, non-fossil fuel capacity stood at 283.46 GW, solar at 150.26 GW, wind at 56.09 GW. Back in June 2025, India crossed the 50% mark for non-fossil fuel capacity, five years ahead of the Paris Agreement schedule.

The Budget 2026-27 gave the renewable energy ministry ₹44,614 crore, a 40% increase over the previous year. The National Green Hydrogen Mission has an initial outlay of ₹19,744 crore. And the 500 GW target by 2030, which once sounded ambitious, now looks very much achievable given the pace things are moving.

Electric Vehicles

Total EV sales in FY26 crossed 24.52 lakh units, up 24.6% from the year before. Electric passenger car sales were up 83.6%. Two-wheelers, which still make up the bulk of the market, accounted for over 14 lakh units. India has now cumulatively sold 8.3 million Electric Vehicles and 88% of that total came in just the last four years. That kind of acceleration is hard to ignore.

The government wants 30% of all vehicles to be electric by 2030. Public charging infrastructure has crossed 12,000 stations. The PM E-DRIVE scheme brings ₹10,900 crore to the table. Customs duty exemptions on capital goods for battery cell manufacturing are also in place to cut down on import dependency.

Healthcare and Pharmaceuticals

India's pharma exports crossed $31 billion in FY26. The country supplies medicines to 191 countries, with roughly half those exports going to tightly regulated markets like the US and Europe. Medical device exports have grown from $2.5 billion in 2020-21 to $4.1 billion in 2024-25.

Budget 2026-27 introduced the Biopharma SHAKTI initiative: ₹10,000 crore over five years to build India into a serious hub for biologics and biosimilar manufacturing. The medical devices sector, currently valued at around ₹1,02,564 crore, is targeting ₹4,27,350 crore by 2030.

Each of these sectors has real momentum behind it, not just government optimism. They're moving. And the larger part of the opportunity is still ahead, which is exactly what makes them worth paying attention to.

Conclusion

Each of these industries comes with official government recognition, budget allotments, and tangible accomplishments instead of mere promises. They have progressed sufficiently to make it clear that they will not fail, but they remain at the beginning stages of their life cycle, where the bulk of the potential still lies. This is the very essence of a sunrise industry, and it is why these industries warrant consideration beyond budgetary considerations.